Company intelligence / Profile preview
Gordion Bioscience
Cambridge, Massachusetts, United Statesgordion.bio ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Preclinical
01
Overview
Gordion Bioscience is developing a platform that integrates patient selection with target identification using comprehensive genomic analysis of real tumor samples. Their primary therapeutic strategy is synthetic lethality, aiming to identify new cancer drug targets that are not detectable in traditional cell line assays. The company was founded in 2023, has raised $120K in seed funding, and is based in Cambridge, Massachusetts. No clinical results have been published yet.
- Therapeutic areas
- Oncology
- Modalities
- Synthetic lethality-based therapeuticsLikely small molecules or targeted therapies (inferred from focus on drug targets and synthetic lethality)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Techstars Berlin Accelerator (investor/accelerator partnership)
Beyond the preview
Go deeper on Gordion Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gordion Bioscience.